Simonian Nancy A 4
4 · Syros Pharmaceuticals, Inc. · Filed Dec 4, 2024
Insider Transaction Report
Form 4
Simonian Nancy A
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-12-02$0.27/sh−37,070$10,016→ 4,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.2680 to $0.2726, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.